BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21214583)

  • 1. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S; Stefanović V; Capkun V
    Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemolytic disease of the newborn caused by anti-c antibodies. Case report].
    Ornat K; Cyran T; Maszkiewicz W
    Acta Haematol Pol; 1988; 19(1-2):75-6. PubMed ID: 3149114
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 9. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
    Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adsorption-elution test of red blood cells].
    Okubo M; Fujii A; Imai A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():798-9. PubMed ID: 20942193
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
    Reiner AP; Teramura G; Aramaki KM
    Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
    Towns D; Hannon J; Hendry J; Barnes J; Goldman M
    Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.